Compound 1588
Identifiers
- Canonical SMILES:
CCCCN(CCCC)C(=O)c1nn(c(C)c1Cl)-c1ccc(NC(=O)COc2ccccc2)cc1C(=O)N1CCc2ccccc2C1
- IUPAC name:
N,N-dibutyl-4-chloro-1-[2-(3,4-dihydro-1H-isoquinoline-2-carbonyl)-4-[(2-phenoxyacetyl)amino]phenyl]-5-methylpyrazole-3-carboxamide
- InChi:
InChI=1S/C37H42ClN5O4/c1-4-6-20-41(21-7-5-2)37(46)35-34(38)26(3)43(40-35)32-18-17-29(39-33(44)25-47-30-15-9-8-10-16-30)23-31(32)36(45)42-22-19-27-13-11-12-14-28(27)24-42/h8-18,23H,4-7,19-22,24-25H2,1-3H3,(H,39,44)
- InChiKey:
JGHBSKWHWQNIKH-UHFFFAOYSA-N
External links
![]() 44570091 |
![]() CHEMBL504480 |
![]() 24709962 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
2 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 7.40 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 655.29 g/mol | |||
HBA | 9 | |||
HBD | 1 | |||
HBA + HBD | 10 | |||
AlogP | 7.01 | |||
TPSA | 96.77 | |||
RB | 13 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 2 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
19027294 | 40 | BCL2 P10415 |
|
Biochemical assay | Time-Resolved FRET | pIC50 (half maximal inhibitory concentration, -log10) | 7.40 | |
19027294 | 40 | B2CL1 Q07817 |
|
Biochemical assay | Time-Resolved FRET | pKi (inhibition constant, -log10) | 5.62 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5742 | Apixaban | DB06605 | |
0.4964 | Meclinertant | DB06455 | |
0.4672 | Danusertib | DB11778 | |
0.4533 | JHU-75528 C-11 | DB14902 | |
0.4480 | Alosetron | DB00969 | |
0.4464 | Rimonabant | DB06155 | |
0.4444 | Surinabant | DB13070 | |
0.4373 | Doramapimod | DB03044 | |
0.4312 | Brilacidin | DB12997 | |
0.4264 | (5S)-5-(2-amino-2-oxoethyl)-4-oxo-N-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)methyl]-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidine-2-carboxamide | DB07397 | |
0.4237 | TAK-593 | DB13093 | |
0.4235 | PF-06291874 | DB15065 | |
0.4226 | (1S)-1-(3-chlorophenyl)-2-oxo-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate | DB08498 | |
0.4208 | Tariquidar | DB06240 | |
0.4205 | Lorlatinib | DB12130 |